| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/05/2005 | US20050095675 Mucin peptide with immunoenhancing properties |
| 05/05/2005 | US20050095667 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins |
| 05/05/2005 | US20050095245 Topical time release dosage form; vaginal conditions |
| 05/05/2005 | US20050095241 Estrogen receptor modulators and uses thereof |
| 05/05/2005 | US20050095239 Methods and compositions for treating Alzheimer's disease |
| 05/05/2005 | US20050095237 Antibodies that kill P2Y10-expressing cells linked to diseases such as inflammatory disorders, autoimmune diseases, allergic reaction, organ and tissue rejection, and mast cell diseases; immunotherapy; use of vaccines; diagnosis |
| 05/05/2005 | US20050095231 Transduction; gene therapy; replacing capsid with chimeric molecule containing heterologous trimerization motif and stabilized scFv ligand; host cells |
| 05/05/2005 | US20050095227 Treating heart failure |
| 05/05/2005 | US20050095225 Altering epithelial sodium channel (ENaC) activity |
| 05/04/2005 | EP1528102A2 Cloning and recombinant productions of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 05/04/2005 | EP1527343A2 Organic compounds |
| 05/04/2005 | EP1527340A2 Method for identifying substances |
| 05/04/2005 | EP1527177A2 Muc-1 antigen with reduced number of vntr repeat units |
| 05/04/2005 | EP1527086A1 Compounds binding to p-selectin |
| 05/04/2005 | EP1527084A2 Promoters exhibiting endothelial cell specificity and methods of using same |
| 05/04/2005 | EP1526840A1 Nanoparticles for dna administration to a target organ |
| 05/04/2005 | EP1442022A4 Polyamide modulators of cox2 transcription |
| 05/04/2005 | EP1221480B1 Polypeptide humanin inhibiting nerve cell death |
| 05/04/2005 | EP1218395B1 Antisense modulation of x-linked inhibitor of apoptosis expression |
| 05/04/2005 | EP1109925B1 Recombinant adenovirus for tissue specific expression in heart |
| 05/04/2005 | EP1061955B1 Polynucleotide composition, method of preparation, and use thereof |
| 05/04/2005 | EP0935001B1 Novel vegf-like factors |
| 05/04/2005 | EP0859857B1 Cationic polyacrylates and poly(alkyl)acrylates or the corresponding acrylamides for use in synthetic transfection systems |
| 05/04/2005 | CN1612890A Novel chimeric tnf ligands |
| 05/04/2005 | CN1612750A TACI-immunoglobulin fusion proteins |
| 05/04/2005 | CN1612746A Use of HEPCIDIN as a regulator of iron homeostasis |
| 05/04/2005 | CN1612717A Method and apparatus for production of a skin graft and the graft produced thereby |
| 05/04/2005 | CN1612691A Methods and compositions for correction of cardiac conduction disturbances |
| 05/04/2005 | CN1611603A Novel DNA fragment and its inhibition from tumour |
| 05/04/2005 | CN1611264A CCA gene vaccine, and its establishing method and use for preparing vaccine for preventing and treating tumour |
| 05/04/2005 | CN1200102C Livestock castration vaccine gene and recombinant gene vector |
| 05/04/2005 | CN1199567C Hybrid matrix implants and explants |
| 05/03/2005 | US6887987 DNA encoding the human serine protease T |
| 05/03/2005 | US6887906 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 05/03/2005 | US6887877 Viricide for hepatitis virus |
| 05/03/2005 | US6887857 Microparticle protection of therapeutic agents |
| 05/03/2005 | US6887856 Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy |
| 05/03/2005 | US6887843 Chlamydia protein, gene sequence and uses thereof |
| 05/03/2005 | US6887704 A cell population cultured ex-vivo in a culture medium under conditions permitting cells of cell population to proliferate and at the same time reducing capacity of cells in utilizing copper, hence expanded yet not further differentiated |
| 05/03/2005 | US6887490 Use in the delivery of therapeutic agents to selected tissues and advantageously has the potential to repair/replace damaged tissue |
| 05/03/2005 | US6887472 That do not cause anaphylaxis, antigenic fusion proteins of given amino acid sequence, of a CH3 domain of an immunoglobulin (IgE) molecule; allergy vaccines; vaccine test methods in dogs |
| 05/03/2005 | US6887466 Activating the population of T cells and stimulating an accessory molecule on the surface of the T cells with a ligand; HIV immunotherapy; T cells can be genetically transduced and used for immunotherapy |
| 05/03/2005 | US6887464 Plurality of genetically engineered nucleocapsid protein monomers derived from duck hepatitis B virus; immune response, gene therapy |
| 05/03/2005 | US6887463 Recombinant viral vector encoding a human very low density lipoprotein (VLDL) receptor, operatively linked to regulatory sequences directing expression in a hepatocyte; familial hypercholesterolemia or hyperlipidemia |
| 05/03/2005 | CA2147623C Novel p-selectin ligand protein |
| 04/30/2005 | CA2553542A1 Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of nad |
| 04/28/2005 | WO2005038035A2 Methods for producing and using in vivo pseudotyped retroviruses |
| 04/28/2005 | WO2005038013A1 Artisense oligonucleotides optimized for kidney targeting |
| 04/28/2005 | WO2005038005A2 Shc proteins as therapeutic targets in proliferative diseases |
| 04/28/2005 | WO2005037999A2 Treatment of cancer using antibodies to lrrc15 |
| 04/28/2005 | WO2005037868A2 Methods of treating nfat-related disorders |
| 04/28/2005 | WO2005037854A2 Immunogenic peptides |
| 04/28/2005 | WO2005037323A2 Use of gro to treat or prevent inflammation |
| 04/28/2005 | WO2005037322A1 Oncogene therapeutic drug |
| 04/28/2005 | WO2005037321A1 Oncogene therapeutic drug |
| 04/28/2005 | WO2005037317A2 Mast cell-derived renin |
| 04/28/2005 | WO2005037233A2 Listeria-based epha2 vaccines |
| 04/28/2005 | WO2005037232A2 Methods and compositions for modulating adipocyte function |
| 04/28/2005 | WO2005037217A2 Lentiviral vector delivery of msp36 for treatment of cancer |
| 04/28/2005 | WO2005037211A2 Methods and compositions for the treatment of neurological disease |
| 04/28/2005 | WO2005037194A2 Collagen interactions with prostate cancer cells |
| 04/28/2005 | WO2005024061A3 Compounds and methods for modulation of dna replication |
| 04/28/2005 | WO2005024059A3 Methods for identifying compounds for inhibiting fever |
| 04/28/2005 | WO2005024033A3 Nucleotide sequences promoting the trans-membrane transport of nucleic acids |
| 04/28/2005 | WO2005023312A3 Methods for transfecting cells using dna minor groove binding agents |
| 04/28/2005 | WO2005014609A3 Method of producing a highly stereoregular phosphorus atom-modified nucleotide analogue |
| 04/28/2005 | WO2005007811A3 Injection of bone marrow-derived cells and medium for angiogenesis |
| 04/28/2005 | WO2005001062A3 Modified vectors for organelle transfection |
| 04/28/2005 | WO2005001023A3 Method and carrier complexes for delivering molecules to cells |
| 04/28/2005 | WO2004098646B1 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 04/28/2005 | WO2004098531A3 Increased transduction using abc transporter substrates and/or inhibitors |
| 04/28/2005 | WO2004064765A3 Herpesvirus amplicon particles |
| 04/28/2005 | WO2004063329A3 Modulation of pten expression via oligomeric compounds |
| 04/28/2005 | WO2004048548A3 Methods for identifying risk of breast cancer and treatments thereof |
| 04/28/2005 | WO2004048524A3 Modulation of stat2 expression |
| 04/28/2005 | WO2004037188A3 Cardiac muscle regeneration using mesenchymal stem cells |
| 04/28/2005 | WO2004032622A3 Production of peptides in plants as viral coat protein fusions |
| 04/28/2005 | WO2004011486A8 Method for solubilizing hydrophobic peptides and use thereof for inducing an antitumoral and/or anti-infectious ctl response |
| 04/28/2005 | WO2003099201A3 Compositions and methods of use for a fibroblast growth factor |
| 04/28/2005 | WO2003095971A3 Posh nucleic acids, polypeptides and related methods |
| 04/28/2005 | WO2003093419A3 Preventing secondary lymphedema with vegf-d dna |
| 04/28/2005 | WO2003087389A3 Biologic modulations with nanoparticles |
| 04/28/2005 | WO2003086276A3 Compositions and methods for portal specific gene delivery and treatment of infection |
| 04/28/2005 | WO2003044170A3 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 04/28/2005 | WO2002072013A8 Method of treating malignancies through induction of blood immune responses |
| 04/28/2005 | US20050091702 Expression of polypeptides in rod outer segment membranes |
| 04/28/2005 | US20050090891 Stent lining |
| 04/28/2005 | US20050090647 Pharmaceutical compositions for treating arthritis and inflammatory disease |
| 04/28/2005 | US20050090646 cytotoxic fusion proteins that are useful for selectively killing endothelial cells in blood vessels that feed tumors |
| 04/28/2005 | US20050090466 Inhibitors of PACE4 for the treatment of arthritis |
| 04/28/2005 | US20050090465 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 04/28/2005 | US20050090464 Vectors for enhanced expression of Vegf for disease treatment |
| 04/28/2005 | US20050090442 administering peptides, polypeptides, proteins or mimetics which correspond to non-membrane associated form of the p75 neurotrophin receptor (p75NTR) death signal region; antiapoptosis |
| 04/28/2005 | US20050090441 inducing prolonged in vivo gene expression in mammal by contacting nonmuscular tissue with a nucleic acid, a histone, and an amphipathic compound; animal models: |
| 04/28/2005 | US20050090440 Tumour treating combinations, compositions and methods |
| 04/28/2005 | US20050090009 Compositions of stabilized DNA for coating microprojctions |
| 04/28/2005 | US20050090006 Nucleic acid molecules which modulate transcription of operably-linked sequences in Schwann cells |
| 04/28/2005 | US20050090000 Novel human 7TM protein and polynucleotides encoding the same |
| 04/28/2005 | US20050089999 Method for the production and purification of adenoviral vectors |
| 04/28/2005 | US20050089984 Having a specific amino acid sequence, especially fused to a heterologous polypeptide; induces apoptosis |